Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-10 of 10 for

Edit search filters
  1. A Study to Evaluate Optimal Target of Activated Clotting Time During Percutaneous Coronary Intervention and Outcomes

    Jacksonville, FL

  2. Early Coronary Angiography Versus Delayed Coronary Angiography

    Rochester, MN

  3. Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion

    Rochester, MN

  4. A Study to Compare Radiation Exposures between Two Standard-of-care Methods of Abdominal Aortic Aneurysm Repair

    Scottsdale/Phoenix, AZ

  5. RAdiolabeled Perfusion to Identify Coronary Artery Disease Using WAter To Evaluate Responses of Myocardial FLOW (RAPID-WATER-FLOW)

    Rochester, MN

  6. Contrast-Enhanced MR Angiography Method in Comparison to Current Methods in Healthy Volunteers

    Rochester, MN

  7. Spontaneous Coronary Artery Dissection: Mechanistic Evaluation

    Rochester, MN

  8. Outcomes of Percutaneous Revascularization for Management of Surgically Ineligible Patients With Multivessel or Left Main Coronary Artery Disease: A Prospective Registry

    Rochester, MN

  9. A Study of Ticagrelor in the Upstream Setting for Non-ST-Segment Elevation Myocardial Infarction

    Jacksonville, FL

  10. Angiogram Based Fractional Flow Reserve FFRangio - A Validation Study

    Rochester, MN

.

Mayo Clinic Footer